Blog

“Anxiety.” The very word evokes discomfort. Its effects—shortness of breath, pounding heart, muscle tension—are outright distressing. And there’s more of it than ever. According to the U.S. Census Bureau, half of young American adults have significant symptoms. It’s no wonder that the anxiety epidemic is causing us much consternation and concern.But, as a clinician and researcher, I see a much bigger problem. In our society’s quest to be anxiety-free, we tend to miss out on many valuable opportunities presented by this normal human emotion.In and of itself, anxiety is not deadly, and it certainly is not a disease or pathology. Quite the contrary: being able to feel anxious shows that our fight-or-flight system is operational, which is an indicator of brain and sensory health. Once we accep...

The U.S. is facing a mystery of missing Adderall—one for which nobody has an answer. Oct. 12 marked one year since the U.S. Food and Drug Administration’s formal announcement that pharmaceutical companies were unable to produce enough Adderall, one of the common amphetamine-based medications for attention-deficit/hyperactivity disorder (ADHD). As a result, many of the 41 million ADHD patients nationwide who rely on the drug daily to stay focused and reduce impulsive behavior have faced refill delays and empty inventories at their pharmacies. Eight drug manufacturers have reported shortages of Adderall, which also means other major ADHD medications are now in short supply after psychiatrists turned to other treatment options for patients. In a year with the highest rate of drug shortages re...